Aubrey Rankin

President, Revance Therapeutics, Inc.

Companies

Revance Therapeutics, Inc.Board member Jul 27, 2020 to Mar 17, 2022¹
Revance Therapeutics, Inc.President Jul 27, 2020 to Dec 6, 2021¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Revance Therapeutics, Inc.415,702 shares²Mar 17, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 15, 2022Shares withheld for tax 1,372 shares at $15.79 of Revance Therapeutics, Inc.²
Dec 3, 2021Bought 30,000 shares at $14.43 of Revance Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRevance Therapeutics, Inc., Board member
2
SEC EDGARRevance Therapeutics, Inc. shares after the filing of Mar 17, 2022
3
SEC EDGARForm 4 filed Dec 6, 2021